CDT Equity Inc (CDT)

Currency in USD
0.130
0.000(0.00%)
Closed·
0.134+0.004(+2.69%)
·
Trading near 52-week Low
CDT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.1250.174
52 wk Range
0.12520,123.750
Key Statistics
Prev. Close
0.13
Open
0.132
Day's Range
0.125-0.174
52 wk Range
0.125-20,123.75
Volume
5.98M
Average Volume (3m)
972.86K
1-Year Change
-99.9993%
Book Value / Share
5,305
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CDT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

CDT Equity Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Earnings

Latest Release
Aug 12, 2026
EPS / Forecast
-8.71 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

CDT Income Statement

Compare CDT to Peers and Sector

Metrics to compare
CDT
Peers
Sector
Relationship
P/E Ratio
0.0x−1.1x−0.3x
PEG Ratio
-−0.020.00
Price/Book
0.0x1.0x2.6x
Price / LTM Sales
-2.5x2.9x
Upside (Analyst Target)
-40.8%65.5%
Fair Value Upside
Unlock22.7%9.5%Unlock

CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company’s pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto’s thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It also provides treatments for inflammatory disorders, oncology, dermatology, rare diseases and animal health. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
66.000.01%8.58
Other Institutional Investors
322.24K28.66%41.89K
Public Companies & Retail Investors
802.21K71.34%104.29K
Total
1.12M100.00%146.19K

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Corvus Capital19.34%217,46228
Primary Development Fund (Cayman) Spc4.47%50,3217

People Also Watch

0.08
WFF
0.00%
0.006
SDST
-56.00%
0.94
AMOD
-5.07%
3.00
GLND
-1.64%

FAQ

What Is the CDT Equity (CDT) Stock Price Today?

The CDT Equity stock price today is 0.130 USD.

What Stock Exchange Does CDT Equity Trade On?

CDT Equity is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for CDT Equity?

The stock symbol for CDT Equity is "CDT."

What Is the CDT Equity (CDT) Afterhours Price Today? (Afterhours variable test: 0.134) Current Date: Oct 24, 2026

After hours price: 0.134. After hours price change (units): 0.004. Price change percentage: 2.690%

What Is the CDT Equity Market Cap?

As of today, CDT Equity market cap is 146.300K USD.

From a Technical Analysis Perspective, Is CDT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has CDT Equity Stock Split?

CDT Equity has split 6 times.

What is the current trading status of CDT Equity (CDT)?

As of Oct 24, 2026, CDT Equity (CDT) is trading at a price of 0.130 USD, with a previous close of 0.130 USD. The stock has fluctuated within a day range of 0.125 USD to 0.174 USD, while its 52-week range spans from 0.125 USD to 20,123.750 USD.

What Is the CDT Premarket Price?

CDT's last pre-market stock price is 0.133 USD. The pre-market share volume is 239,130.000, and the stock has decreased by 0.003, or 2.310%.

What Is the CDT After Hours Price?

CDT's last after hours stock price is 0.134 USD, the stock has decreased by 0.004, or 2.690%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.